Fifth Third Bancorp Paratek Pharmaceuticals, Inc. Call Options Transaction History
Fifth Third Bancorp
- $27.3 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTK
# of Institutions
4Shares Held
1.54MCall Options Held
0Put Options Held
0About Paratek Pharmaceuticals, Inc.
- Ticker PRTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,862,500
- Description
- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...